Heineman Thomas Charles

Heineman Thomas Charles, Chief Medical Officer, accounts for 2 disclosed filings worth $10.0K, all concentrated in ONCOLYTICS BIOTECH INC (ONCY), active 2026. The record is heavily weighted toward buying, with $10.0K in purchases against $0 in sales. The largest single open-market purchase on record is $10.0K in ONCOLYTICS BIOTECH INC. Data is sourced from official SEC Form 3, 4, and 5 filings.